Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Intimation of Earnings Presentation for 9 Months / Quarter 3 - Financial Year 2021-2022 Further to our intimation dated February 14, 2022, regarding approval of un-audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and nine months ended December 31, 2021, we hereby enclose a copy of Earnings Presentation for 9 Months / Quarter 3 - Financial Year 2021-2022. The said Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com Kindly take the same on record.
15-02-2022
Bigul

Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting And Unaudited Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

 In continuation of our intimation dated February 4, 2022, we write to inform you that the Board of Directors of the Company at its meeting held on February 14, 2022 has, inter alia, approved the unaudited financial results for the quarter and nine months ended December 31, 2021 (Standalone and Consolidated) as enclosed. We are enclosing herewith Limited Review Report dated February 14, 2022 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP for the same.
14-02-2022
Bigul

Fermenta Biotech Ltd - 506414 - Board Meeting Outcome for Outcome Of Board Meeting And Unaudited Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

 In continuation of our intimation dated February 4, 2022, we write to inform you that the Board of Directors of the Company at its meeting held on February 14, 2022 has, inter alia, approved the unaudited financial results for the quarter and nine months ended December 31, 2021 (Standalone and Consolidated) as enclosed. We are enclosing herewith Limited Review Report dated February 14, 2022 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP for the same.
14-02-2022
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Earnings conference call under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 to discuss the financial performance of the Company for the quarter and nine months ended December 31, 2021 ['H2/Q3FY22'] Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the earnings conference call is scheduled to be held on Wednesday, February 16, 2022, to discuss the financial performance of the Company for the quarter and nine months ended December 31, 2021.
11-02-2022
Bigul

Fermenta Biotech Ltd - 506414 - Publication Of Notice Of The Meeting Of Board Of Directors Scheduled On February 14, 2022

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter dated February 4, 2022 (sent through BSE website) regarding meeting of the Board of Directors of the Company scheduled on February 14, 2022, we are enclosing herewith photocopy of the newspaper publication published in Business Standard, Mumbai (English version) on page no. 13 and Sakal, Mumbai (Marathi version) on page no. 9 dated February 8, 2022 for your reference and record.
08-02-2022
Bigul

Fermenta Biotech Ltd - 506414 - Closure of Trading Window

 Meeting of Board of Directors of the Company is scheduled to be held on Monday, February 14, 2022, inter alia, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter and nine months ended December 31, 2021. In continuation with our earlier notice for the closure of trading window and in accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company''s Code of Conduct to Regulate, Monitor and Report Trading by Insiders and in terms of BSE Circular LIST/COMP/01/2019-20 dated April 2, 2019, the 'Trading Window" has been closed with effect from January 1, 2022 and shall continue to remain closed till 48 hours after declaration of unaudited financial results for the quarter and nine months ended December 31, 2021.
04-02-2022
Bigul

Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Notice Of Board Meeting And Closure Of Trading Window

 Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company is scheduled to be held on Monday, February 14, 2022, inter alia, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter and nine months ended December 31, 2021.
04-02-2022
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received an intimation from its Registrar and Transfer Agent - Link Intime India Private Limited regarding issue of duplicate share certificate to the shareholder.
04-02-2022
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from Link Intime India Private Limited, Registrar and Transfer Agent about loss of share certificates today i.e. on February 1, 2022
01-02-2022
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

 This corrigendum is pertaining to our intimation made today i.e. on January 31, 2022 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 pursuant to the meeting of the Board held on January 31, 2022 regarding the Scheme of Amalgamation and Arrangement. In second paragraph under serial number b) of 'Annexure 1 - Disclosures regarding the proposed Composite Scheme of Amalgamation and Arrangement', the third sentence was erroneously mentioned as 'Further, Galactico Corporate Services Limited, a SEBI registered Category - I Merchant Banker, has also issued a fairness opinion on the share exchange ratio. ', whereas it should read as : Further, Kunvarji Finstock Private Limited, a SEBI registered Category - I Merchant Banker, has also issued a fairness opinion on the share exchange ratio.
31-01-2022
Next Page
Close

Let's Open Free Demat Account